nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—ABCB1—colon cancer	0.468	1	CbGaD
Doxepin—CYP2C9—Capecitabine—colon cancer	0.0285	0.229	CbGbCtD
Doxepin—CYP1A2—Fluorouracil—colon cancer	0.0188	0.151	CbGbCtD
Doxepin—ABCB1—Irinotecan—colon cancer	0.0171	0.137	CbGbCtD
Doxepin—CYP2C9—Fluorouracil—colon cancer	0.0169	0.136	CbGbCtD
Doxepin—CHRM3—ureter—colon cancer	0.0159	0.128	CbGeAlD
Doxepin—ABCB1—Vincristine—colon cancer	0.0149	0.12	CbGbCtD
Doxepin—ORM1—bile—colon cancer	0.0125	0.101	CbGeAlD
Doxepin—CHRM3—muscle of abdomen—colon cancer	0.0115	0.0923	CbGeAlD
Doxepin—CYP3A4—Irinotecan—colon cancer	0.0102	0.0823	CbGbCtD
Doxepin—ABCB1—Methotrexate—colon cancer	0.00905	0.0727	CbGbCtD
Doxepin—CYP3A4—Vincristine—colon cancer	0.00895	0.0719	CbGbCtD
Doxepin—HTR2A—myenteric nerve plexus—colon cancer	0.00815	0.0655	CbGeAlD
Doxepin—HTR2A—vein—colon cancer	0.00525	0.0422	CbGeAlD
Doxepin—HRH4—bone marrow—colon cancer	0.00427	0.0343	CbGeAlD
Doxepin—ORM1—gall bladder—colon cancer	0.00348	0.0279	CbGeAlD
Doxepin—CHRM5—epithelium—colon cancer	0.00244	0.0196	CbGeAlD
Doxepin—ADRA1D—epithelium—colon cancer	0.00218	0.0176	CbGeAlD
Doxepin—ADRA1B—renal system—colon cancer	0.00207	0.0166	CbGeAlD
Doxepin—HRH2—digestive system—colon cancer	0.00195	0.0156	CbGeAlD
Doxepin—HTR2A—endothelium—colon cancer	0.00181	0.0145	CbGeAlD
Doxepin—HTR2A—blood vessel—colon cancer	0.00167	0.0134	CbGeAlD
Doxepin—HTR2B—smooth muscle tissue—colon cancer	0.00146	0.0118	CbGeAlD
Doxepin—HRH2—liver—colon cancer	0.00145	0.0117	CbGeAlD
Doxepin—CHRM3—smooth muscle tissue—colon cancer	0.00132	0.0106	CbGeAlD
Doxepin—CHRM3—renal system—colon cancer	0.00127	0.0102	CbGeAlD
Doxepin—HTR1A—renal system—colon cancer	0.00126	0.0101	CbGeAlD
Doxepin—ORM1—bone marrow—colon cancer	0.00126	0.0101	CbGeAlD
Doxepin—ADRA1A—epithelium—colon cancer	0.00125	0.0101	CbGeAlD
Doxepin—SLC6A4—digestive system—colon cancer	0.00117	0.00937	CbGeAlD
Doxepin—ADRA1A—renal system—colon cancer	0.00116	0.00935	CbGeAlD
Doxepin—HTR2B—digestive system—colon cancer	0.00116	0.00929	CbGeAlD
Doxepin—KCNH2—renal system—colon cancer	0.00112	0.00903	CbGeAlD
Doxepin—HRH2—lymph node—colon cancer	0.00111	0.00894	CbGeAlD
Doxepin—ADRA2C—renal system—colon cancer	0.00111	0.00891	CbGeAlD
Doxepin—ABCB1—blood vessel—colon cancer	0.00109	0.00878	CbGeAlD
Doxepin—CHRM3—digestive system—colon cancer	0.00104	0.00836	CbGeAlD
Doxepin—HTR2B—vagina—colon cancer	0.00102	0.0082	CbGeAlD
Doxepin—ORM1—liver—colon cancer	0.00102	0.00819	CbGeAlD
Doxepin—HTR2A—embryo—colon cancer	0.000994	0.00799	CbGeAlD
Doxepin—HRH1—epithelium—colon cancer	0.000971	0.00781	CbGeAlD
Doxepin—CYP2C19—digestive system—colon cancer	0.000966	0.00777	CbGeAlD
Doxepin—ADRA1A—lymphoid tissue—colon cancer	0.000966	0.00777	CbGeAlD
Doxepin—CYP1A2—renal system—colon cancer	0.000962	0.00773	CbGeAlD
Doxepin—HRH1—smooth muscle tissue—colon cancer	0.000936	0.00752	CbGeAlD
Doxepin—CYP2C19—vagina—colon cancer	0.000853	0.00686	CbGeAlD
Doxepin—KCNH2—bone marrow—colon cancer	0.00085	0.00683	CbGeAlD
Doxepin—KCNH2—vagina—colon cancer	0.000814	0.00654	CbGeAlD
Doxepin—HTR2A—epithelium—colon cancer	0.000811	0.00652	CbGeAlD
Doxepin—ADRA2C—vagina—colon cancer	0.000803	0.00646	CbGeAlD
Doxepin—CYP1A2—digestive system—colon cancer	0.000789	0.00634	CbGeAlD
Doxepin—ORM1—lymph node—colon cancer	0.000782	0.00628	CbGeAlD
Doxepin—HTR2A—smooth muscle tissue—colon cancer	0.000782	0.00628	CbGeAlD
Doxepin—HTR2A—renal system—colon cancer	0.000752	0.00605	CbGeAlD
Doxepin—CYP2C9—digestive system—colon cancer	0.000749	0.00602	CbGeAlD
Doxepin—HRH1—digestive system—colon cancer	0.000739	0.00594	CbGeAlD
Doxepin—CYP2C19—liver—colon cancer	0.00072	0.00579	CbGeAlD
Doxepin—ADRA1A—liver—colon cancer	0.000711	0.00571	CbGeAlD
Doxepin—CYP3A4—renal system—colon cancer	0.000697	0.0056	CbGeAlD
Doxepin—CYP2D6—renal system—colon cancer	0.000686	0.00551	CbGeAlD
Doxepin—ADRA2C—liver—colon cancer	0.000678	0.00545	CbGeAlD
Doxepin—HTR2B—lymph node—colon cancer	0.00066	0.0053	CbGeAlD
Doxepin—HRH1—vagina—colon cancer	0.000653	0.00524	CbGeAlD
Doxepin—ABCB1—embryo—colon cancer	0.000651	0.00524	CbGeAlD
Doxepin—ADRA2A—vagina—colon cancer	0.000641	0.00515	CbGeAlD
Doxepin—HTR2A—digestive system—colon cancer	0.000617	0.00496	CbGeAlD
Doxepin—CYP1A2—liver—colon cancer	0.000588	0.00473	CbGeAlD
Doxepin—SLC6A2—lymph node—colon cancer	0.000587	0.00471	CbGeAlD
Doxepin—CYP3A4—digestive system—colon cancer	0.000571	0.00459	CbGeAlD
Doxepin—CYP2D6—digestive system—colon cancer	0.000562	0.00452	CbGeAlD
Doxepin—CYP2C9—liver—colon cancer	0.000558	0.00449	CbGeAlD
Doxepin—HTR2A—vagina—colon cancer	0.000545	0.00438	CbGeAlD
Doxepin—ABCB1—epithelium—colon cancer	0.000532	0.00427	CbGeAlD
Doxepin—KCNH2—lymph node—colon cancer	0.000527	0.00423	CbGeAlD
Doxepin—ADRA2C—lymph node—colon cancer	0.00052	0.00418	CbGeAlD
Doxepin—Confusional state—Irinotecan—colon cancer	0.000495	0.00175	CcSEcCtD
Doxepin—Nervous system disorder—Vincristine—colon cancer	0.000494	0.00175	CcSEcCtD
Doxepin—Thrombocytopenia—Vincristine—colon cancer	0.000494	0.00174	CcSEcCtD
Doxepin—ABCB1—renal system—colon cancer	0.000493	0.00396	CbGeAlD
Doxepin—Oedema—Irinotecan—colon cancer	0.000491	0.00174	CcSEcCtD
Doxepin—Myalgia—Fluorouracil—colon cancer	0.00049	0.00173	CcSEcCtD
Doxepin—Chest pain—Fluorouracil—colon cancer	0.00049	0.00173	CcSEcCtD
Doxepin—Infection—Irinotecan—colon cancer	0.000488	0.00172	CcSEcCtD
Doxepin—Hyperhidrosis—Vincristine—colon cancer	0.000487	0.00172	CcSEcCtD
Doxepin—Hepatobiliary disease—Capecitabine—colon cancer	0.000487	0.00172	CcSEcCtD
Doxepin—Discomfort—Fluorouracil—colon cancer	0.000485	0.00171	CcSEcCtD
Doxepin—Shock—Irinotecan—colon cancer	0.000483	0.00171	CcSEcCtD
Doxepin—Nervous system disorder—Irinotecan—colon cancer	0.000481	0.0017	CcSEcCtD
Doxepin—Agranulocytosis—Capecitabine—colon cancer	0.000481	0.0017	CcSEcCtD
Doxepin—Thrombocytopenia—Irinotecan—colon cancer	0.000481	0.0017	CcSEcCtD
Doxepin—Anorexia—Vincristine—colon cancer	0.000481	0.0017	CcSEcCtD
Doxepin—Hyperhidrosis—Irinotecan—colon cancer	0.000475	0.00168	CcSEcCtD
Doxepin—Confusional state—Fluorouracil—colon cancer	0.000474	0.00168	CcSEcCtD
Doxepin—Hypotension—Vincristine—colon cancer	0.000471	0.00167	CcSEcCtD
Doxepin—Bradycardia—Capecitabine—colon cancer	0.000471	0.00166	CcSEcCtD
Doxepin—Oedema—Fluorouracil—colon cancer	0.00047	0.00166	CcSEcCtD
Doxepin—Anorexia—Irinotecan—colon cancer	0.000468	0.00165	CcSEcCtD
Doxepin—Ataxia—Methotrexate—colon cancer	0.000468	0.00165	CcSEcCtD
Doxepin—Infection—Fluorouracil—colon cancer	0.000467	0.00165	CcSEcCtD
Doxepin—Hepatitis—Capecitabine—colon cancer	0.000462	0.00163	CcSEcCtD
Doxepin—Nervous system disorder—Fluorouracil—colon cancer	0.000461	0.00163	CcSEcCtD
Doxepin—Thrombocytopenia—Fluorouracil—colon cancer	0.00046	0.00163	CcSEcCtD
Doxepin—Hypoaesthesia—Capecitabine—colon cancer	0.00046	0.00163	CcSEcCtD
Doxepin—HTR2A—liver—colon cancer	0.00046	0.00369	CbGeAlD
Doxepin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000459	0.00162	CcSEcCtD
Doxepin—Pharyngitis—Capecitabine—colon cancer	0.000459	0.00162	CcSEcCtD
Doxepin—Tachycardia—Fluorouracil—colon cancer	0.000459	0.00162	CcSEcCtD
Doxepin—Hypotension—Irinotecan—colon cancer	0.000459	0.00162	CcSEcCtD
Doxepin—Urinary tract disorder—Capecitabine—colon cancer	0.000457	0.00161	CcSEcCtD
Doxepin—Insomnia—Vincristine—colon cancer	0.000456	0.00161	CcSEcCtD
Doxepin—Oedema peripheral—Capecitabine—colon cancer	0.000456	0.00161	CcSEcCtD
Doxepin—Connective tissue disorder—Capecitabine—colon cancer	0.000454	0.00161	CcSEcCtD
Doxepin—Urethral disorder—Capecitabine—colon cancer	0.000453	0.0016	CcSEcCtD
Doxepin—Paraesthesia—Vincristine—colon cancer	0.000453	0.0016	CcSEcCtD
Doxepin—Breast disorder—Methotrexate—colon cancer	0.00045	0.00159	CcSEcCtD
Doxepin—Anorexia—Fluorouracil—colon cancer	0.000448	0.00158	CcSEcCtD
Doxepin—Insomnia—Irinotecan—colon cancer	0.000444	0.00157	CcSEcCtD
Doxepin—Paraesthesia—Irinotecan—colon cancer	0.000441	0.00156	CcSEcCtD
Doxepin—Hypotension—Fluorouracil—colon cancer	0.000439	0.00155	CcSEcCtD
Doxepin—Decreased appetite—Vincristine—colon cancer	0.000438	0.00155	CcSEcCtD
Doxepin—Dyspnoea—Irinotecan—colon cancer	0.000438	0.00155	CcSEcCtD
Doxepin—Somnolence—Irinotecan—colon cancer	0.000436	0.00154	CcSEcCtD
Doxepin—Gastrointestinal disorder—Vincristine—colon cancer	0.000435	0.00154	CcSEcCtD
Doxepin—Fatigue—Vincristine—colon cancer	0.000435	0.00154	CcSEcCtD
Doxepin—Eye disorder—Capecitabine—colon cancer	0.000432	0.00153	CcSEcCtD
Doxepin—Dyspepsia—Irinotecan—colon cancer	0.000432	0.00153	CcSEcCtD
Doxepin—Tinnitus—Capecitabine—colon cancer	0.000431	0.00152	CcSEcCtD
Doxepin—Pain—Vincristine—colon cancer	0.000431	0.00152	CcSEcCtD
Doxepin—Constipation—Vincristine—colon cancer	0.000431	0.00152	CcSEcCtD
Doxepin—Asthma—Methotrexate—colon cancer	0.00043	0.00152	CcSEcCtD
Doxepin—Flushing—Capecitabine—colon cancer	0.000429	0.00152	CcSEcCtD
Doxepin—Cardiac disorder—Capecitabine—colon cancer	0.000429	0.00152	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000428	0.00151	CcSEcCtD
Doxepin—Decreased appetite—Irinotecan—colon cancer	0.000427	0.00151	CcSEcCtD
Doxepin—Eosinophilia—Methotrexate—colon cancer	0.000426	0.00151	CcSEcCtD
Doxepin—CYP3A4—liver—colon cancer	0.000426	0.00342	CbGeAlD
Doxepin—Insomnia—Fluorouracil—colon cancer	0.000425	0.0015	CcSEcCtD
Doxepin—Gastrointestinal disorder—Irinotecan—colon cancer	0.000424	0.0015	CcSEcCtD
Doxepin—Fatigue—Irinotecan—colon cancer	0.000423	0.0015	CcSEcCtD
Doxepin—Paraesthesia—Fluorouracil—colon cancer	0.000422	0.00149	CcSEcCtD
Doxepin—HRH1—lymph node—colon cancer	0.000422	0.00339	CbGeAlD
Doxepin—Pain—Irinotecan—colon cancer	0.00042	0.00148	CcSEcCtD
Doxepin—Constipation—Irinotecan—colon cancer	0.00042	0.00148	CcSEcCtD
Doxepin—Angiopathy—Capecitabine—colon cancer	0.00042	0.00148	CcSEcCtD
Doxepin—Dyspnoea—Fluorouracil—colon cancer	0.000419	0.00148	CcSEcCtD
Doxepin—CYP2D6—liver—colon cancer	0.000419	0.00337	CbGeAlD
Doxepin—Somnolence—Fluorouracil—colon cancer	0.000418	0.00148	CcSEcCtD
Doxepin—Immune system disorder—Capecitabine—colon cancer	0.000418	0.00148	CcSEcCtD
Doxepin—Mediastinal disorder—Capecitabine—colon cancer	0.000417	0.00147	CcSEcCtD
Doxepin—Chills—Capecitabine—colon cancer	0.000415	0.00147	CcSEcCtD
Doxepin—ADRA2A—lymph node—colon cancer	0.000415	0.00333	CbGeAlD
Doxepin—Dyspepsia—Fluorouracil—colon cancer	0.000414	0.00146	CcSEcCtD
Doxepin—Arrhythmia—Capecitabine—colon cancer	0.000413	0.00146	CcSEcCtD
Doxepin—Gastrointestinal pain—Vincristine—colon cancer	0.000412	0.00146	CcSEcCtD
Doxepin—ABCB1—lymphoid tissue—colon cancer	0.000409	0.00329	CbGeAlD
Doxepin—Decreased appetite—Fluorouracil—colon cancer	0.000409	0.00144	CcSEcCtD
Doxepin—Alopecia—Capecitabine—colon cancer	0.000409	0.00144	CcSEcCtD
Doxepin—Pancytopenia—Methotrexate—colon cancer	0.000408	0.00144	CcSEcCtD
Doxepin—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000406	0.00143	CcSEcCtD
Doxepin—Mental disorder—Capecitabine—colon cancer	0.000405	0.00143	CcSEcCtD
Doxepin—Feeling abnormal—Irinotecan—colon cancer	0.000405	0.00143	CcSEcCtD
Doxepin—ABCB1—digestive system—colon cancer	0.000404	0.00325	CbGeAlD
Doxepin—Erythema—Capecitabine—colon cancer	0.000403	0.00142	CcSEcCtD
Doxepin—Malnutrition—Capecitabine—colon cancer	0.000403	0.00142	CcSEcCtD
Doxepin—Dysuria—Methotrexate—colon cancer	0.000402	0.00142	CcSEcCtD
Doxepin—Pain—Fluorouracil—colon cancer	0.000402	0.00142	CcSEcCtD
Doxepin—Gastrointestinal pain—Irinotecan—colon cancer	0.000401	0.00142	CcSEcCtD
Doxepin—Upper respiratory tract infection—Methotrexate—colon cancer	0.0004	0.00141	CcSEcCtD
Doxepin—Body temperature increased—Vincristine—colon cancer	0.000398	0.00141	CcSEcCtD
Doxepin—Abdominal pain—Vincristine—colon cancer	0.000398	0.00141	CcSEcCtD
Doxepin—Flatulence—Capecitabine—colon cancer	0.000397	0.0014	CcSEcCtD
Doxepin—Erectile dysfunction—Methotrexate—colon cancer	0.000396	0.0014	CcSEcCtD
Doxepin—Dysgeusia—Capecitabine—colon cancer	0.000394	0.00139	CcSEcCtD
Doxepin—Back pain—Capecitabine—colon cancer	0.000389	0.00138	CcSEcCtD
Doxepin—Abdominal pain—Irinotecan—colon cancer	0.000388	0.00137	CcSEcCtD
Doxepin—Body temperature increased—Irinotecan—colon cancer	0.000388	0.00137	CcSEcCtD
Doxepin—Feeling abnormal—Fluorouracil—colon cancer	0.000387	0.00137	CcSEcCtD
Doxepin—Muscle spasms—Capecitabine—colon cancer	0.000387	0.00137	CcSEcCtD
Doxepin—Pneumonia—Methotrexate—colon cancer	0.000386	0.00136	CcSEcCtD
Doxepin—Infestation NOS—Methotrexate—colon cancer	0.000384	0.00136	CcSEcCtD
Doxepin—Drowsiness—Methotrexate—colon cancer	0.000384	0.00136	CcSEcCtD
Doxepin—Infestation—Methotrexate—colon cancer	0.000384	0.00136	CcSEcCtD
Doxepin—Vision blurred—Capecitabine—colon cancer	0.000379	0.00134	CcSEcCtD
Doxepin—Tremor—Capecitabine—colon cancer	0.000377	0.00133	CcSEcCtD
Doxepin—Stomatitis—Methotrexate—colon cancer	0.000374	0.00132	CcSEcCtD
Doxepin—Ill-defined disorder—Capecitabine—colon cancer	0.000374	0.00132	CcSEcCtD
Doxepin—Urticaria—Fluorouracil—colon cancer	0.000374	0.00132	CcSEcCtD
Doxepin—ABCB1—bone marrow—colon cancer	0.000373	0.003	CbGeAlD
Doxepin—Anaemia—Capecitabine—colon cancer	0.000372	0.00132	CcSEcCtD
Doxepin—Body temperature increased—Fluorouracil—colon cancer	0.000372	0.00131	CcSEcCtD
Doxepin—Hypersensitivity—Vincristine—colon cancer	0.000371	0.00131	CcSEcCtD
Doxepin—Sweating—Methotrexate—colon cancer	0.000368	0.0013	CcSEcCtD
Doxepin—Malaise—Capecitabine—colon cancer	0.000363	0.00128	CcSEcCtD
Doxepin—Hepatobiliary disease—Methotrexate—colon cancer	0.000363	0.00128	CcSEcCtD
Doxepin—Vertigo—Capecitabine—colon cancer	0.000362	0.00128	CcSEcCtD
Doxepin—Hypersensitivity—Irinotecan—colon cancer	0.000362	0.00128	CcSEcCtD
Doxepin—Asthenia—Vincristine—colon cancer	0.000362	0.00128	CcSEcCtD
Doxepin—Syncope—Capecitabine—colon cancer	0.000361	0.00128	CcSEcCtD
Doxepin—Leukopenia—Capecitabine—colon cancer	0.00036	0.00127	CcSEcCtD
Doxepin—Agranulocytosis—Methotrexate—colon cancer	0.000358	0.00127	CcSEcCtD
Doxepin—ABCB1—vagina—colon cancer	0.000357	0.00287	CbGeAlD
Doxepin—Palpitations—Capecitabine—colon cancer	0.000356	0.00126	CcSEcCtD
Doxepin—Loss of consciousness—Capecitabine—colon cancer	0.000354	0.00125	CcSEcCtD
Doxepin—Asthenia—Irinotecan—colon cancer	0.000352	0.00125	CcSEcCtD
Doxepin—Cough—Capecitabine—colon cancer	0.000351	0.00124	CcSEcCtD
Doxepin—Hypertension—Capecitabine—colon cancer	0.000348	0.00123	CcSEcCtD
Doxepin—Hypersensitivity—Fluorouracil—colon cancer	0.000346	0.00122	CcSEcCtD
Doxepin—Diarrhoea—Vincristine—colon cancer	0.000345	0.00122	CcSEcCtD
Doxepin—Hepatitis—Methotrexate—colon cancer	0.000344	0.00122	CcSEcCtD
Doxepin—Chest pain—Capecitabine—colon cancer	0.000343	0.00121	CcSEcCtD
Doxepin—Myalgia—Capecitabine—colon cancer	0.000343	0.00121	CcSEcCtD
Doxepin—Arthralgia—Capecitabine—colon cancer	0.000343	0.00121	CcSEcCtD
Doxepin—Pharyngitis—Methotrexate—colon cancer	0.000342	0.00121	CcSEcCtD
Doxepin—Anxiety—Capecitabine—colon cancer	0.000342	0.00121	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00034	0.0012	CcSEcCtD
Doxepin—Urinary tract disorder—Methotrexate—colon cancer	0.00034	0.0012	CcSEcCtD
Doxepin—Discomfort—Capecitabine—colon cancer	0.000339	0.0012	CcSEcCtD
Doxepin—Urethral disorder—Methotrexate—colon cancer	0.000337	0.00119	CcSEcCtD
Doxepin—Diarrhoea—Irinotecan—colon cancer	0.000336	0.00119	CcSEcCtD
Doxepin—Dry mouth—Capecitabine—colon cancer	0.000335	0.00118	CcSEcCtD
Doxepin—Dizziness—Vincristine—colon cancer	0.000333	0.00118	CcSEcCtD
Doxepin—Pruritus—Fluorouracil—colon cancer	0.000333	0.00118	CcSEcCtD
Doxepin—Confusional state—Capecitabine—colon cancer	0.000331	0.00117	CcSEcCtD
Doxepin—Oedema—Capecitabine—colon cancer	0.000329	0.00116	CcSEcCtD
Doxepin—Infection—Capecitabine—colon cancer	0.000326	0.00115	CcSEcCtD
Doxepin—Dizziness—Irinotecan—colon cancer	0.000325	0.00115	CcSEcCtD
Doxepin—Shock—Capecitabine—colon cancer	0.000323	0.00114	CcSEcCtD
Doxepin—Nervous system disorder—Capecitabine—colon cancer	0.000322	0.00114	CcSEcCtD
Doxepin—Eye disorder—Methotrexate—colon cancer	0.000322	0.00114	CcSEcCtD
Doxepin—Diarrhoea—Fluorouracil—colon cancer	0.000322	0.00114	CcSEcCtD
Doxepin—Thrombocytopenia—Capecitabine—colon cancer	0.000322	0.00114	CcSEcCtD
Doxepin—Tinnitus—Methotrexate—colon cancer	0.000321	0.00113	CcSEcCtD
Doxepin—Tachycardia—Capecitabine—colon cancer	0.000321	0.00113	CcSEcCtD
Doxepin—Vomiting—Vincristine—colon cancer	0.000321	0.00113	CcSEcCtD
Doxepin—Cardiac disorder—Methotrexate—colon cancer	0.00032	0.00113	CcSEcCtD
Doxepin—Skin disorder—Capecitabine—colon cancer	0.000319	0.00113	CcSEcCtD
Doxepin—Rash—Vincristine—colon cancer	0.000318	0.00112	CcSEcCtD
Doxepin—Hyperhidrosis—Capecitabine—colon cancer	0.000318	0.00112	CcSEcCtD
Doxepin—Dermatitis—Vincristine—colon cancer	0.000318	0.00112	CcSEcCtD
Doxepin—Headache—Vincristine—colon cancer	0.000316	0.00112	CcSEcCtD
Doxepin—Anorexia—Capecitabine—colon cancer	0.000313	0.00111	CcSEcCtD
Doxepin—Angiopathy—Methotrexate—colon cancer	0.000312	0.0011	CcSEcCtD
Doxepin—Vomiting—Irinotecan—colon cancer	0.000312	0.0011	CcSEcCtD
Doxepin—Immune system disorder—Methotrexate—colon cancer	0.000311	0.0011	CcSEcCtD
Doxepin—Dizziness—Fluorouracil—colon cancer	0.000311	0.0011	CcSEcCtD
Doxepin—Mediastinal disorder—Methotrexate—colon cancer	0.00031	0.0011	CcSEcCtD
Doxepin—Rash—Irinotecan—colon cancer	0.00031	0.00109	CcSEcCtD
Doxepin—Dermatitis—Irinotecan—colon cancer	0.000309	0.00109	CcSEcCtD
Doxepin—Chills—Methotrexate—colon cancer	0.000309	0.00109	CcSEcCtD
Doxepin—Headache—Irinotecan—colon cancer	0.000308	0.00109	CcSEcCtD
Doxepin—Hypotension—Capecitabine—colon cancer	0.000307	0.00109	CcSEcCtD
Doxepin—Alopecia—Methotrexate—colon cancer	0.000304	0.00108	CcSEcCtD
Doxepin—Mental disorder—Methotrexate—colon cancer	0.000302	0.00107	CcSEcCtD
Doxepin—ABCB1—liver—colon cancer	0.000301	0.00242	CbGeAlD
Doxepin—Malnutrition—Methotrexate—colon cancer	0.0003	0.00106	CcSEcCtD
Doxepin—Erythema—Methotrexate—colon cancer	0.0003	0.00106	CcSEcCtD
Doxepin—Nausea—Vincristine—colon cancer	0.000299	0.00106	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000299	0.00106	CcSEcCtD
Doxepin—Vomiting—Fluorouracil—colon cancer	0.000299	0.00106	CcSEcCtD
Doxepin—Insomnia—Capecitabine—colon cancer	0.000297	0.00105	CcSEcCtD
Doxepin—Rash—Fluorouracil—colon cancer	0.000296	0.00105	CcSEcCtD
Doxepin—Dermatitis—Fluorouracil—colon cancer	0.000296	0.00105	CcSEcCtD
Doxepin—Paraesthesia—Capecitabine—colon cancer	0.000295	0.00104	CcSEcCtD
Doxepin—Headache—Fluorouracil—colon cancer	0.000295	0.00104	CcSEcCtD
Doxepin—Dysgeusia—Methotrexate—colon cancer	0.000293	0.00104	CcSEcCtD
Doxepin—Dyspnoea—Capecitabine—colon cancer	0.000293	0.00104	CcSEcCtD
Doxepin—Nausea—Irinotecan—colon cancer	0.000292	0.00103	CcSEcCtD
Doxepin—Back pain—Methotrexate—colon cancer	0.00029	0.00102	CcSEcCtD
Doxepin—Dyspepsia—Capecitabine—colon cancer	0.000289	0.00102	CcSEcCtD
Doxepin—Decreased appetite—Capecitabine—colon cancer	0.000286	0.00101	CcSEcCtD
Doxepin—Gastrointestinal disorder—Capecitabine—colon cancer	0.000284	0.001	CcSEcCtD
Doxepin—Fatigue—Capecitabine—colon cancer	0.000283	0.001	CcSEcCtD
Doxepin—Vision blurred—Methotrexate—colon cancer	0.000282	0.000998	CcSEcCtD
Doxepin—Pain—Capecitabine—colon cancer	0.000281	0.000993	CcSEcCtD
Doxepin—Constipation—Capecitabine—colon cancer	0.000281	0.000993	CcSEcCtD
Doxepin—Nausea—Fluorouracil—colon cancer	0.000279	0.000987	CcSEcCtD
Doxepin—Ill-defined disorder—Methotrexate—colon cancer	0.000278	0.000983	CcSEcCtD
Doxepin—Anaemia—Methotrexate—colon cancer	0.000277	0.000979	CcSEcCtD
Doxepin—Feeling abnormal—Capecitabine—colon cancer	0.000271	0.000957	CcSEcCtD
Doxepin—Malaise—Methotrexate—colon cancer	0.00027	0.000955	CcSEcCtD
Doxepin—Vertigo—Methotrexate—colon cancer	0.000269	0.000952	CcSEcCtD
Doxepin—Gastrointestinal pain—Capecitabine—colon cancer	0.000269	0.00095	CcSEcCtD
Doxepin—Leukopenia—Methotrexate—colon cancer	0.000268	0.000948	CcSEcCtD
Doxepin—Cough—Methotrexate—colon cancer	0.000262	0.000924	CcSEcCtD
Doxepin—Urticaria—Capecitabine—colon cancer	0.000261	0.000923	CcSEcCtD
Doxepin—Abdominal pain—Capecitabine—colon cancer	0.00026	0.000918	CcSEcCtD
Doxepin—Body temperature increased—Capecitabine—colon cancer	0.00026	0.000918	CcSEcCtD
Doxepin—Convulsion—Methotrexate—colon cancer	0.00026	0.000918	CcSEcCtD
Doxepin—Chest pain—Methotrexate—colon cancer	0.000255	0.000902	CcSEcCtD
Doxepin—Arthralgia—Methotrexate—colon cancer	0.000255	0.000902	CcSEcCtD
Doxepin—Myalgia—Methotrexate—colon cancer	0.000255	0.000902	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000253	0.000896	CcSEcCtD
Doxepin—Discomfort—Methotrexate—colon cancer	0.000252	0.000891	CcSEcCtD
Doxepin—Confusional state—Methotrexate—colon cancer	0.000247	0.000872	CcSEcCtD
Doxepin—Infection—Methotrexate—colon cancer	0.000243	0.000859	CcSEcCtD
Doxepin—Hypersensitivity—Capecitabine—colon cancer	0.000242	0.000856	CcSEcCtD
Doxepin—Nervous system disorder—Methotrexate—colon cancer	0.00024	0.000848	CcSEcCtD
Doxepin—Thrombocytopenia—Methotrexate—colon cancer	0.000239	0.000847	CcSEcCtD
Doxepin—Skin disorder—Methotrexate—colon cancer	0.000238	0.00084	CcSEcCtD
Doxepin—Hyperhidrosis—Methotrexate—colon cancer	0.000236	0.000836	CcSEcCtD
Doxepin—Asthenia—Capecitabine—colon cancer	0.000236	0.000833	CcSEcCtD
Doxepin—Anorexia—Methotrexate—colon cancer	0.000233	0.000824	CcSEcCtD
Doxepin—Pruritus—Capecitabine—colon cancer	0.000232	0.000822	CcSEcCtD
Doxepin—ABCB1—lymph node—colon cancer	0.000231	0.00186	CbGeAlD
Doxepin—Hypotension—Methotrexate—colon cancer	0.000229	0.000808	CcSEcCtD
Doxepin—Diarrhoea—Capecitabine—colon cancer	0.000225	0.000795	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000223	0.000788	CcSEcCtD
Doxepin—Insomnia—Methotrexate—colon cancer	0.000221	0.000782	CcSEcCtD
Doxepin—Paraesthesia—Methotrexate—colon cancer	0.00022	0.000776	CcSEcCtD
Doxepin—Dyspnoea—Methotrexate—colon cancer	0.000218	0.000771	CcSEcCtD
Doxepin—Somnolence—Methotrexate—colon cancer	0.000217	0.000769	CcSEcCtD
Doxepin—Dizziness—Capecitabine—colon cancer	0.000217	0.000768	CcSEcCtD
Doxepin—Dyspepsia—Methotrexate—colon cancer	0.000215	0.000761	CcSEcCtD
Doxepin—Decreased appetite—Methotrexate—colon cancer	0.000213	0.000752	CcSEcCtD
Doxepin—Gastrointestinal disorder—Methotrexate—colon cancer	0.000211	0.000746	CcSEcCtD
Doxepin—Fatigue—Methotrexate—colon cancer	0.000211	0.000745	CcSEcCtD
Doxepin—Pain—Methotrexate—colon cancer	0.000209	0.000739	CcSEcCtD
Doxepin—Vomiting—Capecitabine—colon cancer	0.000209	0.000738	CcSEcCtD
Doxepin—Rash—Capecitabine—colon cancer	0.000207	0.000732	CcSEcCtD
Doxepin—Dermatitis—Capecitabine—colon cancer	0.000207	0.000732	CcSEcCtD
Doxepin—Headache—Capecitabine—colon cancer	0.000206	0.000728	CcSEcCtD
Doxepin—Feeling abnormal—Methotrexate—colon cancer	0.000202	0.000712	CcSEcCtD
Doxepin—Gastrointestinal pain—Methotrexate—colon cancer	0.0002	0.000707	CcSEcCtD
Doxepin—Nausea—Capecitabine—colon cancer	0.000195	0.00069	CcSEcCtD
Doxepin—Urticaria—Methotrexate—colon cancer	0.000194	0.000687	CcSEcCtD
Doxepin—Body temperature increased—Methotrexate—colon cancer	0.000193	0.000684	CcSEcCtD
Doxepin—Abdominal pain—Methotrexate—colon cancer	0.000193	0.000684	CcSEcCtD
Doxepin—Hypersensitivity—Methotrexate—colon cancer	0.00018	0.000637	CcSEcCtD
Doxepin—Asthenia—Methotrexate—colon cancer	0.000175	0.00062	CcSEcCtD
Doxepin—Pruritus—Methotrexate—colon cancer	0.000173	0.000612	CcSEcCtD
Doxepin—Diarrhoea—Methotrexate—colon cancer	0.000167	0.000592	CcSEcCtD
Doxepin—Dizziness—Methotrexate—colon cancer	0.000162	0.000572	CcSEcCtD
Doxepin—Vomiting—Methotrexate—colon cancer	0.000156	0.00055	CcSEcCtD
Doxepin—Rash—Methotrexate—colon cancer	0.000154	0.000545	CcSEcCtD
Doxepin—Dermatitis—Methotrexate—colon cancer	0.000154	0.000545	CcSEcCtD
Doxepin—Headache—Methotrexate—colon cancer	0.000153	0.000542	CcSEcCtD
Doxepin—Nausea—Methotrexate—colon cancer	0.000145	0.000514	CcSEcCtD
Doxepin—Clomipramine—ABCB1—colon cancer	7.6e-05	0.168	CrCbGaD
Doxepin—Chlorprothixene—ABCB1—colon cancer	7.57e-05	0.167	CrCbGaD
Doxepin—Trimipramine—ABCB1—colon cancer	6.99e-05	0.154	CrCbGaD
Doxepin—Promethazine—ABCB1—colon cancer	6.73e-05	0.148	CrCbGaD
Doxepin—Desipramine—ABCB1—colon cancer	6.11e-05	0.135	CrCbGaD
Doxepin—Imipramine—ABCB1—colon cancer	5.19e-05	0.114	CrCbGaD
Doxepin—Amitriptyline—ABCB1—colon cancer	5.15e-05	0.114	CrCbGaD
